Skip to main navigation
Logo
  • Careers
  • Contact
  • Home
  • Products
    • Overview
    • DSUVIA
    • Nafamostat - Niyad™
    • Nafamostat – LTX-608
    • Prefilled Syringes
  • Partnering
  • Investors
    • Overview
    • News & Events
    • Stock Information
    • SEC Filings
    • Corporate Governance
    • Shareholder Services
  • Media
    • Overview
    • Press Releases
    • Publications
  • Military
  • Careers
  • Contact

Investors

Contents

SEC Filing Details

Document Details

Form
424B7
Filing Date
May 3, 2022
Document Date
May 3, 2022
Form Description
424B7    
Filing Group
Registration Statements
Company
AcelRx Pharmaceuticals, Inc.
Issuer
ACELRX PHARMACEUTICALS INC

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS
  • Print Page
  • RSS Feeds
  • Overview
  • News & Events
  • Stock Information
  • SEC Filings
  • Corporate Governance
  • Shareholder Services
  

© 2023 AcelRx Pharmaceuticals, Inc. All Rights Reserved.

Privacy Policy | Terms of Use | CA state requirements